Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap)  (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer) Overgo Probe Designer
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

Ontology Browser
Term:
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor (CHEBI:62434)
Annotations: Rat: (9156) Mouse: (9204) Human: (9869) Chinchilla: (0) Bonobo: (0) Dog: (0) Squirrel: (0) Pig: (6)
Parent Terms Term With Siblings Child Terms
1-NA-PP1 
1-NM-PP1 
4,5-dianilinophthalimide  
afatinib +   
afatinib dimaleate 
axitinib  
BE-23372M 
biochanin A +   
bosutinib +   
bosutinib hydrate 
butein  
cabozantinib +   
cabozantinib malate 
canertinib  
dasatinib (anhydrous) +  
dasatinib monohydrate 
DCC-2036 
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor +   
An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1).
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor +   
emodin +   
emodin(1-) 
genistein +   
herbimycin  
hydroxy-2-naphthalenyl-methyl phosphonic acid trisacetoxymethylester 
imatinib +   
imatinib methanesulfonate  
lapatinib  
leflunomide  
masitinib  
melemeleone B 
neratinib  
nilotinib  
nintedanib  
nintedanib esylate 
pazopanib  
pazopanib hydrochloride 
PD173955 +  
piceatannol +  
picropodophyllotoxin  
ponatinib  
ponatinib hydrochloride 
PP121 
radicicol  
regorafenib +   
regorafenib hydrate 
SKLB-677 
sorafenib +   
teriflunomide  
vandetanib +   
WZ4002 

Synonyms
Related Synonyms: AATK inhibitor ;   AATYK inhibitor ;   AATYK2 inhibitor ;   AATYK3 inhibitor ;   ACH inhibitor ;   ALK inhibitor ;   ALK inhibitors ;   ARK inhibitor ;   ATP:[protein]-L-tyrosine O-phosphotransferase (receptor-type) inhibitor ;   ATP:[protein]-L-tyrosine O-phosphotransferase (receptor-type) inhibitors ;   AXL inhibitor ;   BRT inhibitor ;   Bek inhibitor ;   Bfgfr inhibitor ;   Bsk inhibitor ;   C-FMS inhibitor ;   CAK inhibitor ;   CCK4 inhibitor ;   CD115 inhibitor ;   CD135 inhibitor ;   CDw135 inhibitor ;   CFD1 inhibitor ;   CKIT inhibitor ;   CSF1R inhibitor ;   Cek1 inhibitor ;   Cek10 inhibitor ;   Cek11 inhibitor ;   Cek2 inhibitor ;   Cek3 inhibitor ;   Cek5 inhibitor ;   Cek6 inhibitor ;   Cek7 inhibitor ;   DAlk inhibitor ;   DDR1 inhibitor ;   DDR2 inhibitor ;   DKFZp434C1418 inhibitor ;   DRT inhibitor ;   DTK inhibitor ;   Dek inhibitor ;   Drosophila Eph kinase inhibitor ;   EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitors ;   EC 2.7.10.1 inhibitor ;   EC 2.7.10.1 inhibitors ;   ECK inhibitor ;   EDDR1 inhibitor ;   EGFR inhibitor ;   EPH inhibitor ;   EPHA1 inhibitor ;   EPHA2 inhibitor ;   EPHA6 inhibitor ;   EPHA7 inhibitor ;   EPHA8 inhibitor ;   EPHB1 inhibitor ;   EPHB2 inhibitor ;   EPHB3 inhibitor ;   EPHB4 inhibitor ;   EPHT inhibitor ;   EPHT2 inhibitor ;   EPHT3 inhibitor ;   EPHX inhibitor ;   ERBB inhibitor ;   ERBB1 inhibitor ;   ERBB2 inhibitor ;   ERBB3 inhibitor ;   ERBB4 inhibitor ;   ERK inhibitor ;   Ebk inhibitor ;   Eek inhibitor ;   Ehk2 inhibitor ;   Ehk3 inhibitor ;   Elk inhibitor ;   EphB5 inhibitor ;   Eyk inhibitor ;   FGFR1 inhibitor ;   FGFR2 inhibitor ;   FGFR3 inhibitor ;   FGFR4 inhibitor ;   FLG inhibitor ;   FLK1 inhibitor ;   FLK2 inhibitor ;   FLT1 inhibitor ;   FLT2 inhibitor ;   FLT3 inhibitor ;   FLT4 inhibitor ;   FMS inhibitor ;   Fv2 inhibitor ;   HBGFR inhibitor ;   HEK11 inhibitor ;   HEK2 inhibitor ;   HEK3 inhibitor ;   HEK5 inhibitor ;   HEK6 inhibitor ;   HEP inhibitor ;   HER2 inhibitor ;   HER3 inhibitor ;   HER4 inhibitor ;   HGFR inhibitor ;   HSCR1 inhibitor ;   HTK inhibitor ;   IGF1R inhibitor ;   INSR inhibitor ;   INSRR inhibitor ;   IR inhibitor ;   IRR inhibitor ;   JTK12 inhibitor ;   JTK13 inhibitor ;   JTK14 inhibitor ;   JWS inhibitor ;   K-SAM inhibitor ;   KDR inhibitor ;   KGFR inhibitor ;   KIA0641 inhibitor ;   KIAA1079 inhibitor ;   KIAA1459 inhibitor ;   KIT inhibitor ;   KLG inhibitor ;   Kil inhibitor ;   Kin15 inhibitor ;   Kin16 inhibitor ;   LTK inhibitor ;   MCF3 inhibitor ;   MEN2A/B inhibitor ;   MER inhibitor ;   MERTK inhibitor ;   MEhk1 inhibitor ;   MST1R inhibitor ;   MTC1 inhibitor ;   MUSK inhibitor ;   Mdk1 inhibitor ;   Mdk2 inhibitor ;   Mdk5 inhibitor ;   Mep inhibitor ;   Mlk1 inhibitor ;   Mlk2 inhibitor ;   Mrk inhibitor ;   Myk1 inhibitor ;   N-SAM inhibitor ;   NEP inhibitor ;   NET inhibitor ;   NGL inhibitor ;   NOK inhibitor ;   NTRK1 inhibitor ;   NTRK2 inhibitor ;   NTRK3 inhibitor ;   NTRK4 inhibitor ;   NTRKR1 inhibitor ;   NTRKR2 inhibitor ;   NTRKR3 inhibitor ;   NYK inhibitor ;   Neu inhibitor ;   Nsk2 inhibitor ;   Nuk inhibitor ;   PCL inhibitor ;   PDGFR inhibitor ;   PDGFRA inhibitor ;   PDGFRB inhibitor ;   PHB6 inhibitor ;   PTK inhibitor ;   PTK3 inhibitor ;   PTK7 inhibitor ;   RET inhibitor ;   RON inhibitor ;   ROR1 inhibitor ;   ROR2 inhibitor ;   ROS1 inhibitor ;   RSE inhibitor ;   RTK inhibitor ;   RYK inhibitor ;   SEA inhibitor ;   SKY inhibitor ;   STK inhibitor ;   STK1 inhibitor ;   Sek2 inhibitor ;   Sek3 inhibitor ;   Sek4 inhibitor ;   Sfr inhibitor ;   TEK inhibitor ;   TIE inhibitor ;   TIE1 inhibitor ;   TIE2 inhibitor ;   TIF inhibitor ;   TKT inhibitor ;   TRK inhibitor ;   TRKA inhibitor ;   TRKB inhibitor ;   TRKC inhibitor ;   TRKE inhibitor ;   TYK1 inhibitor ;   TYRO10 inhibitor ;   TYRO3 inhibitor ;   TYRO7 inhibitor ;   Tyro11 inhibitor ;   Tyro5 inhibitor ;   Tyro6 inhibitor ;   UFO inhibitor ;   VEGFR1 inhibitor ;   VEGFR2 inhibitor ;   VEGFR3 inhibitor ;   Vik inhibitor ;   YK1 inhibitor ;   Yrk inhibitor ;   anaplastic lymphoma kinase inhibitor ;   anaplastic lymphoma kinase inhibitors ;   ephrin-B3 receptor tyrosine kinase inhibitor ;   insulin receptor protein-tyrosine kinase inhibitor ;   neurite outgrowth regulating kinase inhibitor ;   nork inhibitor ;   novel oncogene with kinase-domain inhibitor ;   receptor protein-tyrosine kinase inhibitor ;   receptor protein-tyrosine kinase inhibitors
Xrefs: Wikipedia:Anaplastic_lymphoma_kinase

paths to the root